Full Exposure – Containing the Risks

Chemical/Biological/Radiological/Nuclear (CBRN) threats can result in mass casualties or disrupt entire ecosystems. CBRN defense initiatives have been part of the discussions for government and healthcare organizations since the early 1950s, examining the need for protective measures for the hazards these threats may present. In recent years, CBRN defense has gained even more traction, with nuclear and biological threats being at the center of political tensions while the reality of increased access to chemicals and materials required for manufacturing weapons continues to be a problem.

With the risks of exposure and the potential to shut down entire operations, CBRN defense aims at mitigating the dangers they pose to our first-responders and healthcare workers’ safety and wellbeing.

The COVID-19 pandemic creating shortages of vital personal protective equipment along with the use of adulterated equipment has reinforced the need for reliable and innovative ways to protect our heroes, providing them with solutions that have been tested, validated, and utilized even in the most complex situations.

Founded in 1999, ISOVAC designs, develops, commercializes, and manufactures products for CBRN isolation, containment, and protection solutions. ISOVAC’s cutting-edge products are designed to mitigate the risks and adverse effects of exposure. As a provider of recognized isolation solutions, ISOVAC has worked with government organizations around the world.

ISOVAC’s flagship product, the CAPSULS™ (Containment And Protection System Utilizing Life Support) is a portable Patient Isolation Unit (PIU) enabling medical intervention through carefully designed features that maintain end-user’s safety while preventing chemical, biological and radiological cross-contamination. Created as a response to the increasing threat of chemical weapons during the Gulf War, the CAPSULS offers protection for first-responders against a broad range of Toxic Industrial Chemical (TIC), Chemical Warfare Agents (CWA), and biological hazards in various forms. The device’s unrivaled portability with improved pack and reduced system weight is designed to be rapidly deployed, allowing patients to be isolated within minutes and allows for safe transportation of patients through aircraft, ambulances, ships, or any other vehicle capable of safely relocating a patient on a standard litter.

The ORCA™ (Operation Rescue Containment Apparatus), specifically designed for use in marine environments, has rapidly gained popularity and approval since its creation, positioning ISOVAC as the sole-source provider of PIU for the U.S. Coast Guard. The unit is built from selectively permeable fabric and exhaust filtering to prevent chemical and biological cross-contamination between an enclosed patient and the external environment during evacuation and transport activities and ensure pathogens containment. Created for the most rigorous conditions, the ORCA is intended to respond to the demand of hoisting operations that requires the litter and has been tested and shown to meet and exceed U.S. Military Target Performance Value (TPV).

With its CAPSULS and ORCA being the only FDA Cleared Class II Medical Devices under 510(k), ISOVAC is the only manufacturer of certified PIUs in the United States.

Finally, with the CBAG™, a Contaminated Human Remain Pouch (CHRP), ISOVAC provides a portable solution with unsurpassed protection for stand-alone transportation of CBR contaminated remains, equipment and field gears, allowing for temporary storage while awaiting decontamination or burial. The CBAG can also offer protection to uncontaminated equipment and supplies during transport in biohazard-contaminated areas.

About ISOVAC

ISOVAC Products LLC is a designer, developer, and manufacturer of CBR isolation, containment and protection of personnel, casualties, remains, equipment and transport assets designed to mitigate the risks and adverse effects of CBR warfare and terrorist attacks, viral outbreaks (e.g., COVID-19, H5N1, SARS, Ebola, etc.), industrial accidents, and natural disasters. ISOVAC leading-edge manufacturing facilities can also draw on the additional capabilities of experienced contract manufacturers as needed. As a manufacturer of medical devices, ISOVAC employs manufacturing processes and production controls compliant with FDA Good Manufacturing Practices (GMP). With over 150 years of combined expertise in product engineering, design, and manufacturing, ISOVAC can quickly respond to customer needs for modifications of existing products or the development of products for new applications in the chemical and biological defense arena.

For more information about ISOVAC’s products sold and distributed by Unifire, visit www.unifireusa.com or contact us at +1 (800) 745.3282 | +1 (509) 535.7746 or via email at inquiries@unifireusa.com

Unifire Awarded US DLA Contract Valued at up to $200 Million

NEWS RELEASE

FOR IMMEDIATE RELEASE

Unifire Awarded US DLA Contract Valued at up to $200 Million

 SPOKANE, WASHINGTON – Unifire Inc. (“Unifire” or the “Company“), a wholly-owned subsidiary of Mission Ready Solutions Inc (“Mission Ready“), a publicly traded company listed on (OTCQX: MSNVF)(TSX Venture: MRS)(FSE: 2R4), is pleased to announce that the Company has been awarded a contract for up to USD $200,000,000 for COTS – Shelter Systems (SPE1C1-22-D-1506) (the “COTS Contract“) in support of the DLA C&T supply chain.

“We are excited to be added to this contract and for the opportunity to continue supporting the DLA,” said Dan Raczykowski, Chief Operating Officer at Unifire. “We are also proud to be the manufacturer of record for certain products currently included in the solicitation.”

“The team at Unifire has put a tremendous amount of time and energy into this solicitation, having been in active discussions since May 2020, and we are extremely pleased to see their efforts coming to fruition,” said Buck Marshall, President and CEO of Mission Ready Solutions. “As we continue to advance, we are confident that our vision and ambitious strategy will successfully position the Company for growth and allow us to further build shareholder value that will reflect in the coming quarters.”

  • Contract Description: Indefinite Delivery – Indefinite Quantity (“IDIQ“) contract to facilitate the delivery of products through the Company’s vendor network in support of the United States Defense Logistics Agency (“DLA“) Troop Support Clothing & Textiles (“C&T“) supply chain
  • Contract Value: Up to USD $200,000,000 (the “Ceiling“)
  • Product Description: Commercial off-the-shelf (“COTS“) Shelter Systems
  • Performance Period: Initial 1-year base ordering period (Dec. 2/21 through Dec. 1/22) and three 1-year option periods (the “Term“)

 DLA COTS – Shelter Systems Program (the “Program”)

 The COTS – Shelter Systems program is a multiple-award, prime vendor contract, that is structured to accommodate the addition of products through the life of the contract. The Program’s supply chain, at present, offers military tents, parts, and support equipment.

COTS Contract Terms

 The IDIQ contract – with an initial 1-year base ordering period and three 1-year option periods – calls for the supply of COTS – Shelter Systems in support of the United States DLA Troop Support Clothing & Textiles supply chain, and specifies a maximum dollar value of USD $200,000,000.

The COTS Contract follows the Company’s May 2, 2020 response to Solicitation number: SPE1C1-18-R-0003.

IDIQ Contracts

Indefinite Delivery-Indefinite Quantity (IDIQ) is a type of contract that provides for an indefinite quantity of supplies or services during a fixed period of time. IDIQ’s are also sometimes called “Task Orders” or “Delivery Order Contracts.”

 

About Unifire Inc.

Unifire, a wholly-owned subsidiary of Mission Ready Solutions Inc., is a designated Small Business and an industry-leading manufacturer and distributor of over 1.5 million military, fire and first-responder products. With extensive knowledge and experience in providing turnkey solutions to the United States Federal Government, Unifire utilizes its time-proven industry relationships and proprietary technology infrastructure to efficiently source and deliver critical, life-saving products in cooperation with government program managers, military and federal contracting offices, base supply centers, and other federal, state and local supply agencies.

For further information on Unifire Inc., please visit UnifireUSA.com or contact us by email at

Inquiries@UnifireUSA.com or by telephone at +1 877.479.7778 (Ext. 5). You can also subscribe to our mailing list at eepurl.com/hzut7z to receive our latest news directly by email.

 

Forward-Looking Disclaimer

This press release contains certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward‐looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward‐looking statements. No assurance can be given that these expectations will prove to be correct and such forward‐looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.

Forward‐looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Unifire’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Unifire undertakes no obligation to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Unifire to predict or assess the impact of each such factor or the extent to which any factor, or combination thereof, may cause results to differ materially from those contained in any forward‐looking statement. Any forward‐looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

Unifire Welcomes ISOVAC Products as part of its vendor network

SPOKANE, WASHINGTON – DECEMBER 6, 2021 – Unifire Inc. (“Unifire” or the “Company“), a wholly-owned subsidiary of Mission Ready Solutions Inc (“Mission Ready“) (TSX Venture: MRS) (OTCQX: MSNVF), proudly announces that ISOVAC Products has joined the Company’s vendor network.

ISOVAC designs, develops, commercializes, and manufactures Chemical/Biological/Radiological (CBR) isolation, containment and protection solutions. ISOVAC’s CAPSULS, CBAG and ORCA are designed to mitigate the risks and adverse effects of CBR warfare, viral outbreaks, industrial accidents and natural disasters while allowing for safe transportation of patients. ISOVAC’s line of products includes FDA cleared medical devices incorporating specialized advanced materials and military/space-grade components that result in superior products of the highest quality and reliability for chemical and biological defense needs.

ISOVAC’s products will be available as part of Unifire’s GSA Schedule 84: Total Solutions for Law Enforcement, Security, Facilities Management, Fire, Rescue Clothing, Marine Craft, and Emergency/Disaster Response.

“We are delighted to join Unifire’s group of vendors and for the opportunity to offer our products through their established contracting vehicles,” said Pete Jenkner, President of ISOVAC Products. “This strategic collaboration will effectively allow us to expand across the U.S. explore new opportunities including Foreign Military Sales (FMS).”

“The COVID-19 pandemic has created shortages of vital personal protective equipment across our nation and increased the awareness of chemical and biological threats and the surge in the use of adulterated equipment has also reinforced the need for reliable and innovative ways to protect our heroes,” said Dan Raczykowski, Chief Operating Officer at Unifire, Inc. “ISOVAC’s motto “Protecting heroes, protecting us” closely matches our core values and will allow us to offer solutions that have been tested, validated and are currently utilized in the most complex situations.”

For any inquiries on ISOVAC’s products or to place an order:

govsales@unifireusa.com

+1 (800) 745.3282 option 2

Unifire sales team will be happy to assist you!

About Unifire Inc.

Unifire, a wholly-owned subsidiary of Mission Ready Solutions Inc., is a designated Small Business and an industry-leading manufacturer and distributor of over 1.5 million military, fire and first-responder products. With extensive knowledge and experience in providing turnkey solutions to the United States Federal Government, Unifire utilizes its time-proven industry relationships and proprietary technology infrastructure to efficiently source and deliver critical, life-saving products in cooperation with government program managers, military and federal contracting offices, base supply centers, and other federal, state and local supply agencies.

For further information on Unifire Inc., please visit UnifireUSA.com or contact us by email at

Inquiries@UnifireUSA.com or by telephone at +1 877.479.7778 (Ext. 5). You can also subscribe to our mailing list at eepurl.com/hzut7z to receive our latest news directly by email.

Unifire Inc.

(Signed “Skip Church”)

Skip Church

President

T: +1 509.535.7746

Forward-Looking Disclaimer

This press release contains certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward‐looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward‐looking statements. No assurance can be given that these expectations will prove to be correct and such forward‐looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release.

Forward‐looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond Unifire’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Unifire undertakes no obligation to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for Unifire to predict or assess the impact of each such factor or the extent to which any factor, or combination thereof, may cause results to differ materially from those contained in any forward‐looking statement. Any forward‐looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.